Immunotherapy tablet helps control asthma in people with house dust mite allergyBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2358 (Published 27 April 2016) Cite this as: BMJ 2016;353:i2358
- Jacqui Wise
Patients with house dust mite allergy related asthma showed improvements in asthma control when given sublingual allergen immunotherapy on top of their usual medicine, research published in JAMA has found.1
Sublingual allergen immunotherapy involves small doses of an allergen contained in a soluble tablet placed under the tongue. In this case the tablet contained extracts from two species of cultivated house dust mite. House dust mite sensitisation is present in as many as half of patients with asthma, and exposure to the house dust mite allergen …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial